US Patent Issued to Nalpropion Pharmaceuticals on April 14 for "Pharmaceutical formulations comprising naltrexone and/or bupropion" (Tennessee Inventors)

ALEXANDRIA, Va., April 15 -- United States Patent no. 12,599,563, issued on April 14, was assigned to Nalpropion Pharmaceuticals LLC (Brentwood, Tenn.).

"Pharmaceutical formulations comprising naltrexone and/or bupropion" was invented by Rob Churchill (Nolensville, Tenn.) and Aaron Chesnut (Nolensville, Tenn.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Described are pharmaceutical formulations comprising naltrexone and/or bupropion. Such pharmaceutical formulations can comprise extended-release, multilayer beads. Also described are methods of administering such formulations, such as for the treatment of overweight or obesity."

The patent was filed on May 19, 2025, under Application No. 19/211,696.

*For ...